Cutaneous pseudovasculitis

American Journal of Dermatopathology

Volumn 29, Issue 1, 2007, Pages 44-55

  Carlson, J Andrew ^a   Chen, Ko Ron ^b  

^a ALBANY MEDICAL COLLEGE   (United States)

^b NONE

Author keywords

Coagulopathy; Embolus; Hemorrhage; Thrombus; Vasculitis; Vaso occlusion

Indexed keywords

AMYLOID; ASCORBIC ACID; BLOOD CLOTTING FACTOR 5 LEIDEN; CALCIUM; COCAINE; COUMARIN; EPHEDRINE; ERGOT DERIVATIVE; ERYTHROPOIETIN; HEMOSIDERIN; PHOSPHOLIPID ANTIBODY; WARFARIN;

ANTIPHOSPHOLIPID SYNDROME; ARTHROPOD; ATHEROSCLEROSIS; BACTERIAL ENDOCARDITIS; BLEEDING; BLOOD CLOTTING DISORDER; BUERGER DISEASE; CALCINOSIS; CHOLESTEROL EMBOLISM; CLINICAL FEATURE; CUTANEOUS PSEUDOVASCULITIS; DIFFERENTIAL DIAGNOSIS; ECCHYMOSIS; FIBRINOLYSIS; FIBROMUSCULAR DYSPLASIA; FULMINATING PURPURA; HAEMOPHILUS INFLUENZAE; HEART MYXOMA; HEMORRHAGIC PSEUDOVASCULITIS; HISTOPATHOLOGY; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; LEG ULCER; LIVEDO VASCULOPATHY; NECROSIS; NEISSERIA MENINGITIDIS; PETECHIA; POLYARTERITIS NODOSA; PRIORITY JOURNAL; PURPURA; RADIATION EXPOSURE; RADIATION INJURY; RASH; RAYNAUD PHENOMENON; REVIEW; SCURVY; SKIN BIOPSY; SKIN BLOOD VESSEL; SKIN NECROSIS; SKIN ULCER; STREPTOCOCCUS PNEUMONIAE; THROMBOCYTOPENIA; THROMBOSIS; VASCULAR AMYLOIDOSIS; VASCULITIS; VASOSPASM;

BLOOD VESSELS; DIAGNOSIS, DIFFERENTIAL; EMBOLISM; HEMORRHAGE; HUMANS; SKIN; SKIN DISEASES, INFECTIOUS; SKIN DISEASES, VASCULAR; THROMBOSIS; VASCULITIS;

EID: 33846864641     PISSN: 01931091     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.dad.0000245195.35106.3c     Document Type: Review

References (118)

1. Grau R. Pseudovasculitis: mechanisms of vascular injury and clinical spectrum. Curr Rheumatol Rep. 2002;4:83-89.
2. Lie JT. Vasculitis simulators and vasculitis look-alikes. Curr Opin Rheumatol. 1992;4:47-55.
3. Sacks KE. Mimickers of Vasculitis. In: Koopman WJ, Moreland LW, eds. Arthritis and Allied Conditions. 15th ed. Philadelphia: Lippincott Williams & Wilkins; 2005.
4. Adcock DM, Hicks MJ. Dermatopathology of skin necrosis associated with purpura fulminans. Semin Thromb Hemost. 1990;16:283-292.
5. Chen KR. Cutaneous Vascular Diseases. In: Tamaki K, Kimura T, eds. Comprehensive Handbook of Clinical Dermatology. Tokyo: Nakayama-Shoten Co.; 2004.
6. Gibson LE. Cutaneous vasculitis update. Dermatol Clin. 2001;19:603-615.
7. Tomizawa K, Sato-Matsumura KC, Kajii N. The coexistence of cutaneous vasculitis and thrombosis in childhood-onset systemic lupus erythematosus with antiphospholipid antibodies. Br J Dermatol. 2003;149:439-441.
8. Rees JD, Lanca S, Marques PV, et al. Prevalence of the antiphospholipid syndrome in primary systemic vasculitis. Ann Rheum Dis. 2006;65:109-111.
9. Rocca PV, Siegel LB, Cupps TR. The concomitant expression of vasculitis and coagulopathy: synergy for marked tissue ischemia. J Rheumatol. 1994;21:556-560.
10. Manna R, Latteri M, Cristiano G, et al. Anticardiolipin antibodies in giant cell arteritis and polymyalgia rheumatica: a study of 40 cases. Br J Rheumatol. 1998;37:208-210.
11. Chen KR. [Livedo (livedoid) vasculitis]. Monthly Book Derma. 2006;110:63-69.
12. Yasue T. Livedoid vasculitis and central nervous system involvement in systemic lupus erythematosus. Arch Dermatol. 1986;122:66-70.
13. Chen KR, Toyohara A, Suzuki A, et al. Clinical and histopathological spectrum of cutaneous vasculitis in rheumatoid arthritis. Br J Dermatol. 2002;147:905-913.
14. Mekkes JR, Loots MA, van der Wal AC, et al. Increased incidence of hypercoagulability in patients with leg ulcers caused by leukocytoclastic vasculitis. J Am Acad Dermatol. 2004;50:104-107.
15. Lotti T. The purpuras. Int J Dermatol. 1994;33:1-10.
16. Rasmussen JE. Puzzling purpuras in children and young adults. J Am Acad Dermatol. 1982;6:67-72.
17. Sardana K, Sarkar R, Sehgal VN. Pigmented purpuric dermatoses: an overview. Int J Dermatol. 2004;43:482-488.
18. de Villiers PC. Simulium dermatitis in man-clinical and biological features in South Africa. A case report. S Afr Med J. 1987;71:523-525.
19. Tanphaichitr VS, Tuchinda M. Severe thrombocytopenic purpura following a bee sting. Ann Allergy. 1982;49:229-231.
20. Fan PC, Chang HN. Hypersensitivity to mosquito bite: a case report. Gaoxiong Yi Xue Ke Xue Za Zhi. 1995;11:420-424.
21. Magro CM, Dawood MR, Crowson AN. The cutaneous manifestations of human parvovirus B19 infection. Hum Pathol. 2000;31:488-497.
22. Nelson DG, Leake J, Bradley J, et al. Evaluation of febrile children with petechial rashes: is there consensus among pediatricians? Pediatr Infect Dis J. 1998;17:1135-1140.
23. Brandtzaeg P, Dahle JS, Hoiby EA. The occurrence and features of hemorrhagic skin lesions in 115 cases of systemic meningococcal disease. NIPH Ann. 1983;6:183-190.
24. Kurokawa I, Endo K, Hirabayashi M. Purpuric drug eruption possibly due to gefinitib (Iressa). Int J Dermatol. 2005;44:167-168.
25. Kramer KE, Yaar M, Andersen W. Purpuric drug eruption secondary to itraconazole. J Am Acad Dermatol. 1997;37:994-995.
26. Borrie P. A purpuric drug eruption caused by carbromal. Br Med J. 1955;4914:645-646.
27. Urbina F, Barrios M, Sudy E. Photolocalized purpura during ciprofloxacin therapy. Photodermatol Photoimmunol Photomed. 2006;22:111-112.
28. Hendrick A. Purpuric rash following treatment with 2- chlorodeoxyadenosine. Clin Lab Haematol. 2001;23:67-68.
29. Cherpelis BS, Fenske NA. Purpuric irritant contact dermatitis induced by Agave americana. Cutis. 2000;66:287-288.
30. Gupta G, Holmes SC, Spence E, et al. Capillaritis associated with interferon-alfa treatment of chronic hepatitis C infection. J Am Acad Dermatol. 2000;43(5 Pt 2):937-938.
31. Tsao H, Lerner LH. Pigmented purpuric eruption associated with injection medroxyprogesterone acetate. J Am Acad Dermatol. 2000;43(2 Pt 1):308-310.
32. Roberts MA, Andrews GR, Caird FI. Skinfold thickness on the dorsum of the hand in the elderly. Age Ageing. 1975;4:8-15.
33. Feinstein RJ, Halprin KM, Penneys NS, et al. Senile purpura. Arch Dermatol. 1973;108:229-232.
34. Hirschmann JV, Raugi GJ. Adult scurvy. J Am Acad Dermatol. 1999;41:895-906.
35. Nguyen RT, Cowley DM, Muir JB. Scurvy: a cutaneous clinical diagnosis. Australas J Dermatol. 2003;44:48-51.
36. Chartier TK, Johnson RA, Kaminer M, et al. Palpable purpura in an elderly man. Arch Dermatol. 2003;139:1363-1368.
37. Francescone MA, Levitt J. Scurvy masquerading as leukocytoclastic vasculitis: a case report and review of the literature. Cutis. 2005;76:261-266.
38. Adelman HM, Wallach PM, Gutierrez F, et al. Scurvy resembling cutaneous vasculitis. Cutis. 1994;54:111-114.
39. Gonzalez-Gay MA, Garcia-Porrua C, Lueiro M, et al. Scurvy can mimick cutaneous vasculitis. Three case reports. Rev Rhum Engl Ed. 1999;66:360-361.
40. Ratnam KV, Su WP, Peters MS. Purpura simplex (inflammatory purpura without vasculitis): a clinicopathologic study of 174 cases. J Am Acad Dermatol. 1991;25:642-647.
41. Carlson JA, Ng BT, Chen KR. Cutaneous Vasculitis Update: Diagnostic Criteria, Classification, Epidemiology, Etiology, Pathogenesis, Evaluation and Prognosis. Am J Dermatopathol. 2005;27:504-528.
42. Carlson JA, Chen KR. Cutaneous Vasculitis Update: neutrophilic small vessel vasculitic syndromes. Am J Dermatopathol. 2006; in press.
43. Conti T, Barnet B. The diagnostic challenge of infective endocarditis: cutaneous vasculitis leading to the diagnosis of infective endocarditis. J Am Board Fam Pract. 2001;14:451-456.
44. Chan HL. Bacterial infections of the skin. II: cutaneous clues to systemic infections. Ann Acad Med Singapore. 1983;12:98-102.
45. Sehgal VN. Lucio's phenomenon/erythema necroticans. Int J Dermatol. 2005;44:602-605.
46. Costa IM, Kawano LB, Pereira CP, et al. Lucio's phenomenon: a case report and review of the literature. Int J Dermatol. 2005;44:566-571.
47. Wold LE, Lie JT. Cardiac myxomas: a clinicopathologic profile. Am J Pathol. 1980;101:219-240.
48. Garcia FVMJ, Sanz-Sanchez T, Aragues M, et al. Cutaneous embolization of cardiac myxoma. Br J Dermatol. 2002;147:379-382.
49. Loche F, Canepelle S, Arlet E, et al. Cutaneous manifestation of left atrial myxoma. Eur J Dermatol. 1999;9:650-651.
50. Greeson DM, Wright JE, Zanolli MD. Cutaneous findings associated with cardiac myxomas. Cutis. 1998;62:275-280.
51. Navarro PH, Bravo FP, Beltran GG. Atrial myxoma with livedoid macules as its sole cutaneous manifestation. J Am Acad Dermatol. 1995;32(5 Pt 2):881-883.
52. Piriou V, Claudel JP, Bastien O, et al. Severe systemic cholesterol embolization after open heart surgery. Br J Anaesth. 1996;77:277-280.
53. Pennington M, Yeager J, Skelton H, et al. Cholesterol embolization syndrome: cutaneous histopathological features and the variable onset of symptoms in patients with different risk factors. Br J Dermatol. 2002;146:511-517.
54. Donohue KG, Saap L, Falanga V. Cholesterol crystal embolization: an atherosclerotic disease with frequent and varied cutaneous manifestations. J Eur Acad Dermatol Venereol. 2003;17:504-511.
55. Falanga V, Fine MJ, Kapoor WN. The cutaneous manifestations of cholesterol crystal embolization. Arch Dermatol. 1986;122:1194-1198.
56. Lie JT. Cholesterol atheromatous embolism. The great masquerader revisited. Pathol Annu. 1992;27(Pt 2):17-50.
57. Borrego L, Gil R, Mazuecos A, et al. Cholesterol embolism to the skin. Clin Exp Dermatol. 1992;17:424-426.
58. Chandrashekariah R, Fresko O, Lynfield YL. Cholesterol embolism: a case report and review of the literature. Cutis. 2001;68:263-267.
59. Salvarani C, Gabriel SE, Gertz MA, et al. Primary systemic amyloidosis presenting as giant cell arteritis and polymyalgia rheumatica. Arthritis Rheum. 1994;37:1621-1626.
60. Handel DW, Roenigk HH Jr., Shainoff J, et al. Necrotizing vasculitis. Etiologic aspects of immunology and coagulopathy. Arch Dermatol. 1975;111:847-852.
61. Williamson AE, Cone LA, Huard GS 2nd. Spontaneous necrosis of the skin associated with cryofibrinogenemia, cryoglobulinemia, and homocystinuria. Ann Vasc Surg. 1996;10:365-369.
62. Boers GH. Hyperhomocysteinemia as a risk factor for arterial and venous disease. A review of evidence and relevance. Thromb Haemost. 1997;78:520-522.
63. Jorg I, Fenyvesi T, Harenberg J. Anticoagulant-related skin reactions. Expert Opin Drug Saf. 2002;1:287-294.
64. Muniesa C, Marcoval J, Moreno A, et al. Coumarin necrosis induced by renal insufficiency. Br J Dermatol. 2004;151:502-504.
65. Chan YC, Valenti D, Mansfield AO, et al. Warfarin induced skin necrosis. Br J Surg. 2000;87:266-272.
66. Childers BJ, Cobanov B. Acute infectious purpura fulminans: a 15 year retrospective review of 28 consecutive cases. Am Surg. 2003;69:86-90.
67. Asherson RA, Cervera R. Unusual manifestations of the antiphospholipid syndrome. Clin Rev Allergy Immunol. 2003;25:61-78.
68. Frances C, Niang S, Laffitte E, et al. Dermatologic manifestations of the antiphospholipid syndrome: two hundred consecutive cases. Arthritis Rheum. 2005;52:1785-1793.
69. Gibson GE, Su WP, Pittelkow MR. Antiphospholipid syndrome and the skin. J Am Acad Dermatol. 1997;36(6 Pt 1):970-982.
70. Thai KE, Barrett W, Kossard S. Reactive angioendotheliomatosis in the setting of antiphospholipid syndrome. Australas J Dermatol. 2003;44:151-155.
71. McMenamin ME, Fletcher CD. Reactive angioendotheliomatosis: a study of 15 cases demonstrating a wide clinicopathologic spectrum. Am J Surg Pathol. 2002;26:685-697.
72. Calamia KT, Balabanova M, Perniciaro C, et al. Livedo (livedoid) vasculitis and the factor V Leiden mutation: additional evidence for abnormal coagulation. J Am Acad Dermatol. 2002;46:133-137.
73. McCalmont CS, McCalmont TH, Jorizzo JL, et al. Livedo vasculitis: vasculitis or thrombotic vasculopathy? Clin Exp Dermatol. 1992;17:4-8.
74. Acland KM, Darvay A, Wakelin SH, et al. Livedoid vasculitis: a manifestation of the antiphospholipid syndrome? Br J Dermatol. 1999;140:131-135.
75. Klein KL, Pittelkow MR. Tissue plasminogen activator for treatment of livedoid vasculitis. Mayo Clin Proc. 1992;67:923-933.
76. Papi M, Didona B, De Pita O, et al. Livedo vasculopathy vs small vessel cutaneous vasculitis: cytokine and platelet P-selectin studies. Arch Dermatol. 1998;134:447-452.
77. Shornick JK, Nicholes BK, Bergstresser PR, et al. Idiopathic atrophie blanche. J Am Acad Dermatol. 1983;8:792-798.
78. Schroeter AL, Diaz-Perez JL, Winkelmann RK, et al. Livedo vasculitis (the vasculitis of atrophie blanche). Immunohistopathologic study. Arch Dermatol. 1975;111:188-193.
79. Grob JJ, Bonerandi JJ. Thrombotic skin disease as a marker of the anticardiolipin syndrome. Livedo vasculitis and distal gangrene associated with abnormal serum antiphospholipid activity. J Am Acad Dermatol. 1989;20:1063-1069.
80. Mimouni D, Ng PP, Rencic A, et al. Cutaneous polyarteritis nodosa in patients presenting with atrophie blanche. Br J Dermatol. 2003;148:789-794.
81. Thomas JR3rd, Winkelmann RK. Vascular ulcers in scleroderma. Arch Dermatol. 1983;119:803-807.
82. Friedman DR, Wolfsthal SD. Cocaine-induced pseudovasculitis. Mayo Clin Proc. 2005;80:671-673.
83. Henry PY, Larre P, Aupy M, et al. Reversible cerebral arteriopathy associated with the administration of ergot derivatives. Cephalalgia. 1984;4:171-178.
84. Kapoor OP. Iatrogenic ergot vasospastic angiitis. A case report. Vasc Surg. 1976;10:58-60.
85. Taubert G, Seboxa T. Histological examination of blood vessels in peripheral gangrene among patients with sporadic outbreak of ergotism. Trop Geogr Med. 1990;42:58-62.
86. Rumbaugh CL, Bergeron RT, Fang HC, et al. Cerebral angiographic changes in the drug abuse patient. Radiology. 1971;101:335-344.
87. Magee R. Saint Anthony's fire revisited. Vascular problems associated with migraine medication. Med J Aust. 1991;154:145-149.
88. Citron BP, Halpern M, McCarron M, et al. Necrotizing angiitis associated with drug abuse. N Engl J Med. 1970;283:1003-1011.
89. Lake CR, Gallant S, Masson E, et al. Adverse drug effects attributed to phenylpropanolamine: a review of 142 case reports. Am J Med. 1990;89:195-208.
90. Stone JR. Intimal hyperplasia in the distal ulnar artery; Influence of gender and implications for the hypothenar hammer syndrome. Cardiovasc Pathol. 2004;13:20-25.
91. Pineda CJ, Weisman MH, Bookstein JJ, et al. Hypothenar hammer syndrome. Form of reversible Raynaud's phenomenon. Am J Med. 1985;79:561-570.
92. Ferris BL, Taylor LM Jr., Oyama K, et al. Hypothenar hammer syndrome: proposed etiology. J Vasc Surg. 2000;31(1 Pt 1):104-113.
93. Singh S, Tai C, Ganz G, et al. Steroid-responsive pleuropericarditis and livedo reticularis in an unusual case of adult-onset primary hyperoxaluria. Am J Kidney Dis. 1999;33:e5.
94. Baethge BA, Sanusi ID, Landreneau MD, et al. Livedo reticularis and peripheral gangrene associated with primary hyperoxaluria. Arthritis Rheum. 1988;31:1199-1203.
95. Bogle MA, Teller CF, Tschen JA, et al. Primary hyperoxaluria in a 27-year-old woman. J Am Acad Dermatol. 2003;49:725-728.
96. Au S, Crawford RI. Three-dimensional analysis of a calciphylaxis plaque: clues to pathogenesis. J Am Acad Dermatol. 2002;47:53-57.
97. Oh DH, Eulau D, Tokugawa DA, et al. Five cases of calciphylaxis and a review of the literature. J Am Acad Dermatol. 1999;40(6 Pt 1):979-987.
98. Parker RW, Mouton CP, Young DW, et al. Early recognition and treatment of calciphylaxis. South Med J. 2003;96:53-55.
99. Doctoroff A, Purcell SM, Harris J, et al. Protracted calciphylaxis, Part II. Cutis. 2003;72:149-154.
100. Worth RL. Calciphylaxis: pathogenesis and therapy. J Cutan Med Surg. 1998;2:245-248.
101. Breathnach SM, Wells GC. Amyloid vascular disease: cord-like thickening of mucocutaneous arteries, intermittent claudication and angina in a case with underlying myelomatosis. Br J Dermatol. 1980;102:591-595.
102. Jennette JC, Sheps DS, McNeill DD. Exclusively vascular systemic amyloidosis with visceral ischemia. Arch Pathol Lab Med. 1982;106:323-327.
103. Grundmann JU, Bonnekoh B, Gollnick H. Extensive haemorrhagic-bullous skin manifestation of systemic AA-amyloidosis associated with IgGlambda-myeloma. Eur J Dermatol. 2000;10:139-142.
104. Naldi L, Marchesi L, Locati F, et al. Unusual manifestations of primary cutaneous amyloidosis in association with Raynaud's phenomenon and livedo reticularis. Clin Exp Dermatol. 1992;17:117-120.
105. Henry RB, 3rd, Fisher GB, Jr., Cooper PH. Vascular amyloid in a patient with multiple myeloma. J Am Acad Dermatol. 1986;15(2 Pt 2):379-382.
106. Ratz JL, Bailin PL. Cutaneous amyloidosis. A case report of the tumefactive variant and a review of the spectrum of clinical presentations. J Am Acad Dermatol. 1981;4:21-26.
107. Lee DD, Huang CY, Wong CK. Dermatopathologic findings in 20 cases of systemic amyloidosis. Am J Dermatopathol. 1998;20:438-442.
108. Ortonne N, Vignon-Pennamen MD, Majdalani G, et al. Reactive angioendotheliomatosis secondary to dermal amyloid angiopathy. Am J Dermatopathol. 2001;23:315-319
109. Boulware RJ, Allison JR, Jr., Harding SA. Radiation dermatitis: a case report. Cutis. 1981;27:623-624.
110. Fajardo LF, Berthrong M. Radiation injury in surgical pathology. Part III. Salivary glands, pancreas and skin. Am J Surg Pathol. 1981;5:279-296.
111. Landthaler M, Hagspiel HJ, Braun-Falco O. Late irradiation damage to the skin caused by soft X-ray radiation therapy of cutaneous tumors. Arch Dermatol. 1995;131:182-186.
112. Hymes SR, Strom EA, Fife C. Radiation dermatitis: clinical presentation, pathophysiology, and treatment 2006. J Am Acad Dermatol. 2006;54:28-46.
113. Steinert M, Weiss M, Gottlober P, et al. Delayed effects of accidental cutaneous radiation exposure: fifteen years of follow-up after the Chernobyl accident. J Am Acad Dermatol. 2003;49:417-423.
114. McCready RA, Hyde GL, Bivins BA, et al. Radiation-induced arterial injuries. Surgery. 1983;93:306-312.
115. Kalman PG, Lipton IH, Provan JL, et al. Radiation damage to large arteries. Can J Surg. 1983;26:88-91.
116. Butler MJ, Lane RH, Webster JH. Irradiation injury to large arteries. Br J Surg. 1980;67:341-343.
117. Reddy SM, Pui JC, Gold LI, et al. Postirradiation morphea and subcutaneous polyarteritis nodosa: case report and literature review. Semin Arthritis Rheum. 2005;34:728-734.
118. Gottlober P, Bezold G, Weber L, et al. The radiation accident in Georgia: clinical appearance and diagnosis of cutaneous radiation syndrome. J Am Acad Dermatol. 2000;42:453-458.